Unresectable Hepatocellular Carcinoma
Oncology
2
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 3 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Chengdu New RadiomedicineChina - Chengdu
2 programs1
1
NRT6003 InjectionPhase 31 trial
NRT6003 InjectionPhase 11 trial
Active Trials
AstraZenecaCAMBRIDGE, United Kingdom
1 programImfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) StudyN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
Chengdu New RadiomedicineNRT6003 Injection
Chengdu New RadiomedicineNRT6003 Injection
BayerAtezolizumab
AstraZenecaImfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
Clinical Trials (4)
Total enrollment: 1,500 patients across 4 trials
Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Start: Apr 2025Est. completion: Dec 2027
Phase 3Recruiting
Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma
Start: Aug 2023Est. completion: Jun 2025
Phase 1Completed
An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery
Start: Nov 2023Est. completion: Feb 2027300 patients
N/ARecruiting
Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study
Start: May 2023Est. completion: Jul 20251,200 patients
N/ACompleted
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 actively recruiting trials targeting 1,500 patients
3 companies competing in this space